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Although the etiologies of both trapped lung and cardiomegaly are well-established, co-presentation of
the two conditions, and possible interactions between them, are much rarer. Here we describe the case of
78 year-old male found to have both cardiomegaly and trapped lung, with a cause of death of congestive
heart failure and subsequent cardiac arrest. This case prompted consideration of possible interactions
between the two conditions. Issues related to decision-making for imaging and clinical interventions are
also discussed.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
A trapped lung, or ﬁbrothorax, is a shrunken lung surrounded by
a cortex of ﬁbrotic visceral pleura. This ﬁbrotic peel prevents inﬂa-
tion of the lung, and is typically caused by a chronic inﬂammatory
process leading to uncontrolled ﬁbrin deposition. Although it is a
known sequela of recurrent pleural effusion, other disease pro-
cesses, such as malignant or metastatic visceral pleural disease, can
also lead to trapped lung [1,10,14,18]. Cardiomegaly is deﬁned as an
increase in heart size caused by ventricular hypertrophy or chamber
dilation such that the ratio of heart diameter to maximum thorax
diameter, measured transversely, is greater than 0.5 [24]; [25].
Although neither trapped lung nor cardiomegaly is considered
unusual, simultaneous presentation of both conditions, or a causal
connection between them, is virtually unmentioned in the litera-
ture. Furthermore, both conditions can be difﬁcult to diagnose with
a plain chest radiograph, which is the most common imaging or-
dered for patients with dyspnea. Failure to recognize and identify
trapped lung can lead to unnecessary interventions such as
repeated thoracenteses, or can delay more appropriate in-
terventions such as surgical decortication.e Ohio State University, 279
0, USA.
).
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During routine dissection of a 78 year-old male cadaver we
found a trapped left lung and enlarged heart almost completely
occupying the left pleural cavity (Fig. 1). The subject's past medical
history included congestive heart failure (CHF), chronic pleural
effusion with prior thoracenteses, atrial ﬁbrillation, non-sustained
ventricular tachycardia, stage III kidney disease, hypertension,
chronic anemia, cardiac pacemaker placement, and hydrocephalus
with ventriculoperitoneal shunt placement. Cause of death was
given as cardiac arrest and CHF.
One week prior to death, our subject was admitted to the hos-
pital with complaints of shortness of breath and diffuse edema, and
was given primary diagnoses of anasarca and CHF exacerbation. At
that time his vital signs were normal, and he required 2 L of oxygen
by nasal cannula to maintain an oxygen saturation of 95%. Multiple
chest radiographs taken during that hospital stay (Fig. 2) showed
“persistent subtotal opaciﬁcation of the left hemithorax,” and
“massive left pleural effusionwith minimal aeration of the left lung
[and] at least mild cardiomegaly.” The subject then underwent
thoracentesis to remove the ﬂuid in his left hemithorax, and a
repeat radiograph showed “persistent opaciﬁcation” of the left
hemithorax, and noted that “cardiac and mediastinal contours are
difﬁcult to evaluate due to adjacent opaciﬁcation.”
At the time of our dissection, the subject's right lung appearednder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Anterior view of lungs and pericardial sac after removal of the anterior chest
wall. Note the tip of superior lobe of left lung protruding over the left contour of the
heart (arrow).
Fig. 2. Chest radiograph taken during the week before death. Note opaciﬁcation in left
pleural cavity which limits visualization of the heart contours and the trapped lung.
Fig. 3. Anterior view of the chest after removal of the heart, showing deformed and
ﬁbrotic left lung. Note diminutive left lower lobe (arrow).
Fig. 4. Heart opened to show hypertrophy of ventricular walls and interventricular
septum.
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deformed, and markedly diminished compared with the right lung,
particularly in the lower lobe (Fig. 3). The thickness of the cortex
around the lung varied from 0.5 to 1.5 mm. Subject presented with
cardiomegaly, with a cardiothoracic ratio of 0.54. The right ven-
tricular wall, interventricular septum and left ventricular wall
measured 240%, 255%, and 326% of values for healthy adults,
respectively (Fig. 4), indicating substantial biventricular hypertro-
phy [11,15]. Comparing ventricular wall thickness values can be
challenging because norms are based on end-diastolic measure-
ments, and signiﬁcant regional variations exist in the thickness of
any individual ventricle [5]. Wall thickness has been shown to be
greatest during systole; however, the maximum differences in
ventricular thickness measured at diastole and systole have been
reported to average less than 62% [23]. Given this fact, the mea-
surements in the present subject would appear to represent sub-
stantial hypertrophy regardless of the cardiac phase at the time of
death.3. Discussion
3.1. Etiology and clinical course of trapped lung and cardiomegaly
Trapped lung causes a hydropneumothorax, with both ﬂuid and
air present in the pleural cavity. Signs and symptoms of trapped
lung include shortness of breath, an absence of breath sounds on
the affected side and, in some cases, hypoxemia [1,8]. Diagnosis is
made by clinical exam, chest xray and computed tomography (CT).
Analysis of the pleural ﬂuid is done to differentiate malignant from
inﬂammatory or infectious processes. Although ultrasound guid-
ance can greatly enhance the accuracy of thoracentesis for pleural
effusion, it is not considered a reliable imaging modality to identify
a trapped lung [7]; [18].
Chronic pleural effusion is a known cause of trapped lung. In the
early stages of pleural effusion, before the development of the
ﬁbrotic cortex, lung expansion is limited only by the pleural ﬂuid
build-up separating visceral from parietal pleura. Thus, when the
ﬂuid is removed by thoracentesis, the lung is able to fully re-
expand. Over time, however, the thickening ﬁbrotic coat on the
visceral pleura prevents the re-expansion of the lung, even after
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trapped lung is unknown, and in many cases, individuals with
trapped lung are asymptomatic and the condition remains undi-
agnosed [14]. In cases where a patient is symptomatic, decortica-
tion, i.e. surgical removal of the ﬁbrotic cortex, is the standard of
care if the patient is considered a good surgical candidate ( [1,14].
Chronic pleural effusion is caused most commonly by cancer,
followed by left heart failure and pneumonia. There have, however,
been a small number of reported cases of pleural effusion caused by
isolated right ventricular failure [16,17]. The underlyingmechanism
of pleural effusion caused by left ventricular failure results from
increased pulmonary capillary pressure creating an increased
pressure gradient, leading tomovement of ﬂuid from the capillaries
into the pulmonary interstitial space, then across the visceral
pleural membrane into the pleural space [9,16].
Cardiomegaly results either from chamber dilation or, as seen in
the present subject, hypertrophy of one or both ventricles [22,25].
Ventricular hypertrophy has been shown to be a sequela of chronic,
uncontrolled hypertension, although recent research has shown
mutations in the gene coding for sarcomeric proteins to also be an
important cause of hypertrophic cardiomyopathy [6,21,22]. Arterial
hypertension causes increased afterload, and the left ventricular
hypertrophic response. This hypertrophy ultimately leads to
reduced compliance of the left ventricle and subsequent decreased
end diastolic volumes, and thus to CHF [22] [3]. Right ventricular
hypertrophy, which was also seen in the present subject, results
from a chronic increase in afterload due to pulmonary hyperten-
sion, often caused by prior left heart failure [19].
We have found only one reference to the co-presentation of
cardiomegaly and trapped lung in the literature. Our literature
search methodology included database searches of PubMed and
Web of Science, and identical search results were obtained for all
keywords for both databases. Using the keywords of cardiomegaly,
trapped lung, ﬁbrothorax, and heart failure, in various combina-
tions, yielded one article by Ref. [4]. In this article, the authors re-
ported on a case of cardiomegaly and right sided heart failure,
associated with ﬁbrothorax, in a 57 year-old woman, who had
reportedly been asymptomatic since the likely onset of right lung
collapse 39 years prior. The patient was treated with surgical
decortication, and had transient improvement in pulmonary
function tests, although she died of heart failure three years later.
3.2. Evidence of a reciprocal effect between trapped lung and
cardiomegaly
Was the presence of both a trapped lung and enlarged heart in
the present subject a coincidence, or was there some sort of
causation? Although no direct causal connection has been estab-
lished between the two conditions, analogies can be found in the
literature.
For example, right ventricular ejection fraction has been shown
to decrease after pneumonectomy or major pulmonary resection
due to lung cancer. This lower ejection fraction is the result of an
increase in afterload due to the missing pulmonary vascular bed of
the missing or resected lung. Increased afterload is known to cause
right ventricular hypertrophy and ultimately right heart failure
[13]. It is possible that the small and non-functioning left trapped
lung in the present subject led to a similarly increased afterload and
thus compensatory right ventricular hypertrophy.
Conversely, the increased size of the subject's heart may have
contributed to the collapse of his left lung. It has been shown that
increased heart size will cause compression of the left lung, and
cardiomegaly is signiﬁcantly correlated with decreased left lower
lobe ventilation, particularly in the supine position [2,20]. Neves
et al. [12] studied the effect of increased heart weight in 17 patientsundergoing coronary artery bypass grafting. Post-surgical edema
and other mechanisms caused an average 32% increase in post-
surgical heart weight. Using CT scans they were able to measure
pre- and post-surgical volumes and masses of both the heart and
lungs, and measure the pressure of individual cardiac segments on
adjacent lung segments. One day after surgery, they found in-
creases of 75% and 45% in the pressure of the heart on the left and
right lower lobes, respectively; and signiﬁcantly decreased gas
volumes in those lobes. They hypothesize that this pressure of heart
on lung plays an important role in the post-surgical atelectasis
commonly seen after open heart surgery. The present subject
showed grossly decreased size in his left lower lobe (Fig. 3) that is
consistent with the above-described mechanism.
3.3. Clinical considerations
Our subject had three chest radiographs in the ﬁnal week before
his death, in order to monitor his pleural effusion before and after
thoracentesis. Visualization of a trapped lung would require CT
scanning [14]. Yet given the subject's clinical presentation and end-
stage progression of his CHF it is highly unlikely that further in-
terventions for trapped lung, if it had been identiﬁed, would have
been recommended, as surgical decortication is a very invasive
procedure that requires good cardiopulmonary reserve.
Our subject may have beneﬁtted, however, from earlier identi-
ﬁcation of his trapped lung in prior years as hewas being treated for
pleural effusion. Early identiﬁcation may have offered additional
treatment options, and also would have prevented the cost,
discomfort and risks of repeat thoracentesis. Thoracentesis is not
recommended in the case of trapped lung, as the pleural cavity will
immediately reﬁll due to the negative pleural pressure [14]. Greater
awareness, and a higher overall index of suspicion among clinicians
for the presence of trapped lung and its sequelae, would lead to
more routine use of CT scans in similar cases, and likely overall
improved, and potentially more efﬁcient, patient care.
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